Lindbrook Capital, LLC Mersana Therapeutics, Inc. Transaction History

Lindbrook Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$4.63 - $8.0 $2,060 - $3,560	445 New	445 $3,000
Q2 2022 Aug 01, 2022	SELL	$2.84 - $5.0 $1,871 - $3,295	-659 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$3.74 - $6.63 $2,464 - $4,369	659 New	659 $3,000
Q3 2020 Nov 03, 2020	SELL	$16.2 - $25.7 $8,100 - $12,850	-500 Closed	0 $0
Q2 2020 Jul 27, 2020	BUY	$5.24 - $23.4 $2,620 - $11,700	500 New	500 $12,000
Q1 2020 Apr 22, 2020	SELL	$4.41 - $9.28 $8,820 - $18,560	-2,000 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$1.45 - $6.73 $2,900 - $13,460	2,000 New	2,000 $11,000

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $211M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.